Scientists develop protein to track brain's faint chemical signals

Researchers have engineered a protein that detects subtle glutamate signals between neurons, unveiling a previously hidden aspect of brain communication. This tool allows real-time observation of how brain cells process incoming information, potentially advancing studies on learning, memory, and neurological disorders. The findings, published in Nature Methods, highlight a breakthrough in neuroscience.

The brain's neurons communicate through electrical and chemical signals, but until now, scientists could only observe the outgoing electrical messages, leaving incoming chemical exchanges largely invisible. A new protein sensor, iGluSnFR4—pronounced 'glue sniffer'—changes that by capturing faint glutamate releases at synapses in real time. Glutamate, the brain's primary excitatory neurotransmitter, is crucial for processes like learning and memory, yet its brief, weak signals have been hard to measure.

Engineered by teams at the Allen Institute and HHMI's Janelia Research Campus, iGluSnFR4 acts as a molecular indicator sensitive enough to detect even the smallest synaptic events. This enables researchers to see how individual neurons integrate thousands of inputs before deciding to fire, shedding light on complex brain computations underlying thoughts and decisions.

"It's like reading a book with all the words scrambled and not understanding the order of the words or how they're arranged," explained Kaspar Podgorski, a lead author and senior scientist at the Allen Institute. "What we have invented here is a way of measuring information that comes into neurons from different sources, and that's been a critical part missing from neuroscience research."

The tool also holds promise for disease research. Disruptions in glutamate signaling are implicated in conditions including Alzheimer's disease, schizophrenia, autism, and epilepsy. By precisely monitoring these signals, scientists can better understand disease mechanisms and test potential therapies.

Collaboration was key to the sensor's success. "The success of iGluSnFR4 stems from our close collaboration started at HHMI's Janelia Research Campus between the GENIE Project team and Kaspar's lab," said Jeremy Hasseman, a scientist at Janelia. The protein is now available to researchers via Addgene, fostering wider use in neuroscience.

This advance bridges a gap in observing full neural conversations, moving beyond fragmented views to comprehensive insights into brain function.

Articoli correlati

Realistic depiction of GluD2 glutamate receptor activating as an ion channel via D-serine and GABA, with Johns Hopkins neuroscientists in a lab setting.
Immagine generata dall'IA

Johns Hopkins team finds delta-type glutamate receptors function as ligand-gated ion channels

Riportato dall'IA Immagine generata dall'IA Verificato

Johns Hopkins Medicine researchers report that delta-type ionotropic glutamate receptors (GluDs)—long debated as to whether they conduct ions—can act as ligand-gated ion channels. The Nature study used cryo-electron microscopy and membrane recording experiments to characterize human GluD2 and found it can be activated by the neurotransmitters D-serine and GABA, findings the authors say could help guide drug development for disorders linked to GluD mutations.

Researchers have uncovered how amyloid beta and inflammation may both trigger synapse pruning in Alzheimer's disease through a common receptor, potentially offering new treatment avenues. The findings challenge the notion that neurons are passive in this process, showing they actively erase their own connections. Led by Stanford's Carla Shatz, the study suggests targeting this receptor could preserve memory more effectively than current amyloid-focused drugs.

Riportato dall'IA

Scientists at Brown University have identified a subtle brain activity pattern that can forecast Alzheimer's disease in people with mild cognitive impairment up to two and a half years in advance. Using magnetoencephalography and a custom analysis tool, the researchers detected changes in neuronal electrical signals linked to memory processing. This noninvasive approach offers a potential new biomarker for early detection.

Researchers at Scripps Research have developed a blood test that detects Alzheimer's disease by analyzing structural changes in blood proteins. The method identifies differences in three specific proteins, allowing accurate distinction between healthy individuals, those with mild cognitive impairment, and Alzheimer's patients. Published in Nature Aging on February 27, 2026, the findings could enable earlier diagnosis and treatment.

Riportato dall'IA

Researchers at the University of California, San Francisco, have discovered a mechanism by which exercise helps protect the brain from age-related damage associated with Alzheimer's disease. Physical activity prompts the liver to release an enzyme that repairs the blood-brain barrier, reducing inflammation and improving memory in older mice. The findings, published in the journal Cell, highlight a body-to-brain pathway that could lead to new therapies.

Rice University scientists say they have created the first complete, label-free molecular atlas of an Alzheimer’s brain in an animal model, combining hyperspectral Raman imaging with machine learning to map chemical changes that appear unevenly across brain regions and extend beyond amyloid plaques.

Riportato dall'IA

Researchers at The University of Osaka have developed ultra-small pores in silicon nitride membranes that approach the scale of natural ion channels. These structures enable repeatable opening and closing through voltage-controlled chemical reactions. The advance could aid DNA sequencing and neuromorphic computing.

 

 

 

Questo sito web utilizza i cookie

Utilizziamo i cookie per l'analisi per migliorare il nostro sito. Leggi la nostra politica sulla privacy per ulteriori informazioni.
Rifiuta